Aptus Pharma IPO description – Aptus Pharma is a pharmaceutical marketing and distribution company operating on an asset-light, contract manufacturing model. The company does not own manufacturing facilities but collaborates with seven manufacturing units, including two under formal loan and license agreements. As of 31 March 2025, Aptus Pharma markets 194 pharmaceutical formulations across over 11 therapeutic segments, such as anti-infectives, gastrointestinal, cardiovascular, neuro-psychiatric, and wellness products. Its offerings span multiple dosage forms, including tablets, capsules, syrups, injections, and ointments.
Aptus operates through four specialized divisions: Pioneer (acute therapies), CD Care (chronic therapies), Wellcare (OTC and wellness), and Global (export-focused, yet to commence exports). The company has a sales network of 54 field personnel and over 125 direct and sub-distributors. Its centralized warehousing facility spans 17,721 sq. ft. in Ahmedabad, Gujarat, its largest revenue-generating market. It has an established presence in Gujarat and West Bengal and plans expansion into five more Indian states.
Aptus products are manufactured by third-party WHO-GMP certified units in Gujarat, Himachal Pradesh, and Uttarakhand. As of May 2025, Aptus employs 70 permanent staff.
Promoters of Aptus Pharma – Tejash Maheshchandra Hathi, Milly Chetan Lalseta, Riddhish Natwarlal Tanna, Kapilbhai Hasmukhbhai Chandarana, Ghanshyam Vinubhai Pansuriya, Chatrabhuj Vallabhbhai Butani, Gaurang Rameshchandra Thakker, Kripaliben Mayank Thakker and Kunjal Piyushbhai Unadkat
Table of Contents
Aptus Pharma IPO Details
| Aptus Pharma IPO Dates | 23 – 25 September 2025 |
| Aptus Pharma Issue Price | INR 65 – 70 per share |
| Fresh Issue | 18,60,000 shares (INR 12.09 – 13.02 crore) |
| Offer For Sale | Nil |
| Total IPO Size | 18,60,000 shares (INR 12.09 – 13.02 crore) |
| Minimum Bid | 4,000 shares (INR 2,80,000) |
| Lot Size | 2,000 shares (INR 1,40,000) |
| Face Value | INR 10 per share |
| Individual Allocation | 35% |
| Listing On | BSE SME |
Aptus Pharma Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Revenue | 13.90 | 17.86 | 24.56 |
| Expenses | 13.60 | 16.76 | 20.44 |
| Net income | 0.19 | 0.80 | 3.10 |
Aptus Pharma Offer News
- Aptus Pharma RHP
- Aptus Pharma Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- Highest SME IPO Subscription in 2025
Aptus Pharma Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 | |
| EPS | 1.30 | 5.32 | 6.37 |
| PE ratio | – | – | 10.20 – 10.99 |
| RONW (%) | 20.06 | 45.18 | 44.50 |
| NAV | 32.28 | 58.88 | 13.93 |
| ROCE (%) | 12.77 | 21.70 | 45.66 |
| EBITDA (%) | 4.13 | 8.35 | 19.31 |
| Debt/Equity | 2.28 | 3.00 | 1.49 |
Aptus Pharma IPO GMP Today
| Date | Consolidated IPO GMP | Subject to Sauda |
| 29 September 2025 | 4 | 6,000 |
| 27 September 2025 | 5 | 6,500 |
| 26 September 2025 | 5 | 6,500 |
| 25 September 2025 | 7 | 10,200 |
| 24 September 2025 | 7 | 10,200 |
| 23 September 2025 | 7 | 10,200 |
| 22 September 2025 | 7 | 10,200 |
Aptus Pharma IPO Subscription – Live Updates
| Category | QIB | NII | Individual | Total |
|---|---|---|---|---|
| Shares Offered | 3,52,000 | 2,66,000 | 6,20,000 | 12,38,000 |
| 25 Sep 2025 | 1.24 | 29.11 | 31.54 | 22.40 |
| 24 Sep 2025 | 0.81 | 6.51 | 5.48 | 4.37 |
| 23 Sep 2025 | 0.00 | 4.78 | 1.77 | 1.92 |
The market maker reservation portion of 94,000 shares and the anchor investor portion of 5,28,000 shares are not included in the above calculations.
Aptus Pharma IPO Allotment Status
Aptus Pharma IPO allotment status is now available on Bigshare Services website. Click on this link to get the allotment status.
Aptus Pharma IPO Dates & Listing Performance
| IPO Opening Date | 23 September 2025 |
| IPO Closing Date | 25 September 2025 |
| Finalization of Basis of Allotment | 26 September 2025 |
| Initiation of refunds | 29 September 2025 |
| Transfer of shares to demat accounts | 29 September 2025 |
| IPO Listing Date | 30 September 2025 |
| Opening Price on BSE SME | INR 80.80 per share (up 15.43%) |
| Closing Price on BSE SME | INR 84.84 per share (up 21.20%) |
Aptus Pharma Offer Lead Manager
INTERACTIVE FINANCIAL SERVICES LIMITED
Office No. 508, Fifth Floor, Priviera,
Nehru Nagar, Ahmedabad – 380 015, Gujarat
Phone: +91-9898055647
Email: [email protected]
Website: www.ifinservices.in
Aptus Pharma Offer Registrar
BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Pinnacle Business Park,
Mahakali Caves Road, next to Ahura Centre,
Andheri East, Mumbai- 400093, Maharashtra
Phone: +91 22 6263 8200
Email: [email protected]
Website: www.bigshareonline.com
Aptus Pharma Contact Details
APTUS PHARMA LIMITED
SHREE Building 1st Floor Opp Satyasai Heart Hospital,
Narayan Nagar Kalawad Road, Rajkot Sau
Uni Area Rajkot, Gujarat, 360005
Phone: +91 76004 27827
E-mail: [email protected]
Website: www.aptus-pharma.com
IPO FAQs
What is the size of the Aptus Pharma offer?
Aptus Pharma offer size is INR 12.09 – 13.02 crores.
What is the Aptus Pharma offer price band?
Aptus Pharma public offer price is INR 65 – 70 per share.
What is the lot size of the Aptus Pharma IPO?
Aptus Pharma offer lot size is 2,000 shares.
What is the Aptus Pharma IPO GMP today?
Aptus Pharma IPO GMP today is INR 4 per share.
What is the Aptus Pharma kostak rate today?
Aptus Pharma kostak rate today is INR NA per application.
What is the Aptus Pharma IPO Subject to Sauda rate today?
Aptus Pharma Subject to Sauda rate today is INR 6,000 per application.